The resources, designed to improve patient airway care, include the Center’s "Gold Standard" Airway CME courses, its new Difficult Airway iPhone app, online educational center, and pocket guide and textbook.
Exacerbation severity in patients with COPD can be reliably assessed with the COPD Assessment Test (CAT), providing the possibility of a reliable standardized method for assessing such symptoms in COPD patients.
Two recently published perspectives in the Annals of Internal Medicine seek to address the controversy about balancing scientific discovery with public safety.
A new study has revised the cost burden sharply upward for childhood asthma due to pollution.
The Spiro PD allows patients with lung diseases, including asthma, COPD, cystic fibrosis, and lung transplants, to monitor their lung function at any time.
A new review looks at published studies of FDA warnings and alerts about unanticipated risks from approved medications and finds that the success of such communications is “varied and unpredictable.”
A review of the last 20 years of smoking cessation research finds improvements in cessation aids, however, current policy may undermine smokers’ belief in their ability to quit on their own.
The randomized trial was stopped because of safety concerns, leading the researchers to recommend against routine use of intravenous salbutamol in ventilated patients with ARDS.
Roche, the drug’s manufacturer, is still withholding access to full trial data on the drug, despite promises to release the information over 2 years ago, according to the latest Cochrane analysis.
Researchers have found that neonatal caffeine therapy for apnea of prematurity does not significantly improve the rate of survival without disability of low birth weight babies.